Skip to main content
. 2023 Feb 23;9(3):427–439. doi: 10.1021/acscentsci.2c01351

Figure 1.

Figure 1

Distributions of modulated NF-κB and IRF activity from primary screen. RAW Dual cells transcription factor activity for IRF (A), and NF-κB (B) 24 h after addition of modulator + agonist. Modulator (N = 3147) + agonist (N = 13) activity reported as a fold change compared to agonist alone activity. Inhibition and enhancement over multiple orders of magnitude is observed.